GB2485850B - Methods and compositions for detecting copy number and chromosome aneuploidy by ligation probes and partitioning the ligated products prior to amplification - Google Patents

Methods and compositions for detecting copy number and chromosome aneuploidy by ligation probes and partitioning the ligated products prior to amplification

Info

Publication number
GB2485850B
GB2485850B GB1100787.9A GB201100787A GB2485850B GB 2485850 B GB2485850 B GB 2485850B GB 201100787 A GB201100787 A GB 201100787A GB 2485850 B GB2485850 B GB 2485850B
Authority
GB
United Kingdom
Prior art keywords
syndrome
probe
ligation
partitioning
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1100787.9A
Other versions
GB2485850C (en
GB201100787D0 (en
GB2485850A (en
Inventor
Benjamin Joseph Hindson
Serge Saxonov
Philip Belgrader
Kevin Dean Ness
Michael Lucero
Billy Wayne Colston Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
Original Assignee
Bio Rad Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories Inc filed Critical Bio Rad Laboratories Inc
Priority claimed from PCT/US2010/058124 external-priority patent/WO2011066476A1/en
Publication of GB201100787D0 publication Critical patent/GB201100787D0/en
Publication of GB2485850A publication Critical patent/GB2485850A/en
Application granted granted Critical
Publication of GB2485850B publication Critical patent/GB2485850B/en
Publication of GB2485850C publication Critical patent/GB2485850C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/682—Signal amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855—Ligating adaptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Methods to determine nucleic acid copy numbers within a genetic material, such as chromosome number for the detection of foetal genetic or chromosomal diseases such as trisomy or tetraploidy in Downâ s syndrome, trisomy 8, Kleinfelterâ s syndrome, Patau syndrome, Edwards syndrome or XXX syndrome are disclosed wherein a first ligation probe (half-probe) specific for a first target sequence is hybridised to a target nucleic acid, a second ligation probe (half-probe) specific for a second target sequence is hybridised to an adjacent nucleic acid sequence and the two half-probes are joined by ligation prior to partitioning, preferably in an water-in-oil emulsion and subjected to quantitative amplification, preferably by a quantitative PCR approach. A microcapsule comprising a solid-phase exterior and an aqueous phase containing a ligated probe and a water-in-oil mixture comprising a ligation probes are also disclosed.
GB1100787.9A 2009-11-25 2010-11-25 Methods and compositions for detecting copy number and chromosome aneuploidy by ligation probes and partitioning the ligated products prior to amplification Active GB2485850C (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US26459109P 2009-11-25 2009-11-25
US30984510P 2010-03-02 2010-03-02
US30983710P 2010-03-02 2010-03-02
US31763910P 2010-03-25 2010-03-25
US34106510P 2010-03-25 2010-03-25
US31763510P 2010-03-25 2010-03-25
US34121810P 2010-03-25 2010-03-25
US31768410P 2010-03-25 2010-03-25
US38098110P 2010-09-08 2010-09-08
US40910610P 2010-11-01 2010-11-01
US10947310P 2010-11-02 2010-11-02
US41076910P 2010-11-05 2010-11-05
PCT/US2010/058124 WO2011066476A1 (en) 2009-11-25 2010-11-25 Methods and compositions for detecting genetic material

Publications (4)

Publication Number Publication Date
GB201100787D0 GB201100787D0 (en) 2011-03-02
GB2485850A GB2485850A (en) 2012-05-30
GB2485850B true GB2485850B (en) 2014-01-29
GB2485850C GB2485850C (en) 2019-01-23

Family

ID=44066935

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1100787.9A Active GB2485850C (en) 2009-11-25 2010-11-25 Methods and compositions for detecting copy number and chromosome aneuploidy by ligation probes and partitioning the ligated products prior to amplification

Country Status (3)

Country Link
CN (1) CN102985552B (en)
CA (1) CA2767028A1 (en)
GB (1) GB2485850C (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10221442B2 (en) 2012-08-14 2019-03-05 10X Genomics, Inc. Compositions and methods for sample processing
US10400280B2 (en) 2012-08-14 2019-09-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
US20140155295A1 (en) 2012-08-14 2014-06-05 10X Technologies, Inc. Capsule array devices and methods of use
US9951386B2 (en) 2014-06-26 2018-04-24 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11591637B2 (en) 2012-08-14 2023-02-28 10X Genomics, Inc. Compositions and methods for sample processing
US9701998B2 (en) 2012-12-14 2017-07-11 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10273541B2 (en) 2012-08-14 2019-04-30 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10323279B2 (en) 2012-08-14 2019-06-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10752949B2 (en) 2012-08-14 2020-08-25 10X Genomics, Inc. Methods and systems for processing polynucleotides
US20150376609A1 (en) 2014-06-26 2015-12-31 10X Genomics, Inc. Methods of Analyzing Nucleic Acids from Individual Cells or Cell Populations
EP2931919B1 (en) 2012-12-14 2019-02-20 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10533221B2 (en) 2012-12-14 2020-01-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
CN108753766A (en) * 2013-02-08 2018-11-06 10X基因组学有限公司 Polynucleotides bar code generating at
EP2986762B1 (en) * 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
WO2015013681A1 (en) * 2013-07-25 2015-01-29 Bio-Rad Laboratories, Inc. Genetic assays
US10395758B2 (en) 2013-08-30 2019-08-27 10X Genomics, Inc. Sequencing methods
CN104169929B (en) * 2013-09-10 2016-12-28 深圳华大基因股份有限公司 For determining system and the device of fetus whether existence numerical abnormalities of chromosomes
US9824068B2 (en) 2013-12-16 2017-11-21 10X Genomics, Inc. Methods and apparatus for sorting data
CA2943624A1 (en) 2014-04-10 2015-10-15 10X Genomics, Inc. Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same
EP4235677A3 (en) 2014-06-26 2023-11-22 10X Genomics, Inc. Processes and systems for nucleic acid sequence assembly
CN104032031A (en) * 2014-07-04 2014-09-10 华东理工大学 PCR analyzing method for quantitatively detecting nucleic acid through RNA polymerase and ligase coupled reaction medium
EP3212807B1 (en) 2014-10-29 2020-09-02 10X Genomics, Inc. Methods and compositions for targeted nucleic acid sequencing
US9975122B2 (en) 2014-11-05 2018-05-22 10X Genomics, Inc. Instrument systems for integrated sample processing
SG11201705615UA (en) 2015-01-12 2017-08-30 10X Genomics Inc Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same
WO2016115273A1 (en) 2015-01-13 2016-07-21 10X Genomics, Inc. Systems and methods for visualizing structural variation and phasing information
AU2016219480B2 (en) 2015-02-09 2021-11-11 10X Genomics, Inc. Systems and methods for determining structural variation and phasing using variant call data
US10697000B2 (en) 2015-02-24 2020-06-30 10X Genomics, Inc. Partition processing methods and systems
AU2016222719B2 (en) 2015-02-24 2022-03-31 10X Genomics, Inc. Methods for targeted nucleic acid sequence coverage
CN105936930A (en) * 2015-03-04 2016-09-14 松下知识产权经营株式会社 DNA detection method and DNA detection device
CN105969655A (en) * 2015-03-10 2016-09-28 松下知识产权经营株式会社 Method for analyzing multiple nucleic acid targets
EP3329010B1 (en) * 2015-07-29 2019-07-10 Progenity, Inc. Nucleic acids and methods for detecting chromosomal abnormalities
KR101848438B1 (en) * 2015-10-29 2018-04-13 바이오코아 주식회사 A method for prenatal diagnosis using digital PCR
WO2017074094A1 (en) * 2015-10-29 2017-05-04 Biocore Co., Ltd. A method for prenatal diagnosis using digital pcr.
CN115369161A (en) 2015-12-04 2022-11-22 10X 基因组学有限公司 Methods and compositions for nucleic acid analysis
WO2017138984A1 (en) 2016-02-11 2017-08-17 10X Genomics, Inc. Systems, methods, and media for de novo assembly of whole genome sequence data
CN105821482B (en) * 2016-04-29 2018-04-10 李星军 A kind of biochemistry micro- reaction system, high-flux sequence build storehouse instrument and application
WO2017197338A1 (en) 2016-05-13 2017-11-16 10X Genomics, Inc. Microfluidic systems and methods of use
US10550429B2 (en) 2016-12-22 2020-02-04 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10815525B2 (en) 2016-12-22 2020-10-27 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10011872B1 (en) 2016-12-22 2018-07-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
WO2018140966A1 (en) 2017-01-30 2018-08-02 10X Genomics, Inc. Methods and systems for droplet-based single cell barcoding
CN110870018A (en) 2017-05-19 2020-03-06 10X基因组学有限公司 System and method for analyzing a data set
US10844372B2 (en) 2017-05-26 2020-11-24 10X Genomics, Inc. Single cell analysis of transposase accessible chromatin
EP4230746A3 (en) 2017-05-26 2023-11-01 10X Genomics, Inc. Single cell analysis of transposase accessible chromatin
CN107619827B (en) * 2017-09-12 2020-11-13 广州阳普医疗科技股份有限公司 Composition, preparation method thereof and application thereof in field of preservation of free DNA (deoxyribonucleic acid) in whole blood
CN111051523B (en) 2017-11-15 2024-03-19 10X基因组学有限公司 Functionalized gel beads
US10829815B2 (en) 2017-11-17 2020-11-10 10X Genomics, Inc. Methods and systems for associating physical and genetic properties of biological particles
SG11202009889VA (en) 2018-04-06 2020-11-27 10X Genomics Inc Systems and methods for quality control in single cell processing
CN112424377A (en) * 2018-04-17 2021-02-26 克罗玛科德公司 Method and system for multiplex analysis
WO2021252733A2 (en) * 2020-06-10 2021-12-16 Bonadea Diagnostics, Llc Sequence conversion reaction

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007147079A2 (en) * 2006-06-14 2007-12-21 Living Microsystems, Inc. Rare cell analysis using sample splitting and dna tags
WO2010036352A1 (en) * 2008-09-23 2010-04-01 Quantalife, Inc Droplet-based assay system
US20100173394A1 (en) * 2008-09-23 2010-07-08 Colston Jr Billy Wayne Droplet-based assay system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007087312A2 (en) * 2006-01-23 2007-08-02 Population Genetics Technologies Ltd. Molecular counting
DK1991698T3 (en) * 2006-03-01 2014-03-10 Keygene Nv "High-throughput" -sekvensbaseret detection of SNPs using ligeringsassays
EP2481815B1 (en) * 2006-05-11 2016-01-27 Raindance Technologies, Inc. Microfluidic devices

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007147079A2 (en) * 2006-06-14 2007-12-21 Living Microsystems, Inc. Rare cell analysis using sample splitting and dna tags
WO2010036352A1 (en) * 2008-09-23 2010-04-01 Quantalife, Inc Droplet-based assay system
US20100173394A1 (en) * 2008-09-23 2010-07-08 Colston Jr Billy Wayne Droplet-based assay system

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Breast Cancer Research and Treatment 120 (2010) Moelans et al 'Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification' 1-7 *
Clinical Chemistry 56 (2010) Guo et al 'Simultaneous Detection of Trisomies 13, 18, and 21 with Multiplex Ligation-Dependent Probe Amplification-Based Real-Time PCR' 1451-1459 *
European Journal of Human Genetics 13 (2005) Gerdes et al 'Computer-assisted prenatal aneuploidy screening for chromosome 13, 18, 21, X and Y based on multiplex ligation-dependent probe amplification (MLPA)' 171-175 *
European Journal of Human Genetics 17 (2009) Van Opstal et al 'Rapid aneuploidy detection with multiplex ligation-dependent probe amplification: a prospective study of 4000 amniotic fluid samples' 112-121 *
Lab on a Chip 10 (2010) Leng et al 'Agarose droplet microfluidics for highly parallel and efficient single molecule emulsion PCR' 2841-2843 *
Methods in Molecular Biology 444 (2008) Schouten 'MLPA for prenatal diagnosis of commonly occurring aneuploidies' 111-122 *
Methods in Molecular Biology 556 (2009) Ji and Welch 'Molecular inversion probe assay for allelic quantitation' 67-87 *
Nucleic Acids Research 33 (2005) Wang et al 'Allele quantification using molecular inversion probes (MIP)' e183 *
Obstetrics & Gynecology 115 (2010) Boormans et al 'Comparison of Multiplex Ligation-Dependent Probe Amplification and Karyotyping in Prenatal Diagnosis' 297-303 *
Prenatal Diagnosis 25 (2005) Hochstenbach et al 'Rapid detection of chromosomal aneuploidies in uncultured amniocytes by multiplex ligation-dependent probe amplification (MLPA)' 1032-1039 *

Also Published As

Publication number Publication date
GB2485850C (en) 2019-01-23
GB201100787D0 (en) 2011-03-02
CN102985552A (en) 2013-03-20
GB2485850A (en) 2012-05-30
CN102985552B (en) 2016-02-17
CA2767028A1 (en) 2011-06-03

Similar Documents

Publication Publication Date Title
GB2485850B (en) Methods and compositions for detecting copy number and chromosome aneuploidy by ligation probes and partitioning the ligated products prior to amplification
Hatzi et al. A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters
Jamonnak et al. Yeast Nrd1, Nab3, and Sen1 transcriptome-wide binding maps suggest multiple roles in post-transcriptional RNA processing
Valouev et al. A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning
Zhang et al. On the analysis of the illumina 450k array data: probes ambiguously mapped to the human genome
WO2008094902A3 (en) Compositions and methods for the detection of a nucleic acid using a cleavage reaction
WO2012019187A3 (en) Ligation-based detection of genetic variants
MX340330B (en) Method and product for localised or spatial detection of nucleic acid in a tissue sample.
BR112014025262A8 (en) “methods for quantifying a specific product in a cut-off amplification reaction, for detecting a plurality of distinct reaction products produced over the course of a single reaction, for real-time monitoring of a cut-off amplification reaction, for monitoring in real-time a target nucleic acid molecule in an extend and cut amplification reaction, to monitor in real time a target nucleic acid molecule in a test sample, and to amplify a polynucleotide, kit, and isolated oligonucleotide
GB201200658D0 (en) Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence
BR112014009269A8 (en) diagnosis of fetal chromosomal aneuploidy
WO2012116220A3 (en) Materials and methods for detection of hpv nucleic acid
WO2009018003A3 (en) Detection assays and use thereof
WO2008069906A3 (en) Digital expression of gene analysis
JP2011511949A5 (en)
WO2013040491A3 (en) Probe: antiprobe compositions for high specificity dna or rna detection
EP2314680A4 (en) Method for amplification of target nucleic acid sequence, method for detection of mutation by using the method, and reagents for use in the methods
BR112015013234A2 (en) multiplex nucleic acid detection methods
WO2007103558A3 (en) Hybrid energy transfer for nucleic acid detection
WO2011153354A8 (en) Methods and kits for in situ detection of nucleotide sequences
EP2582849A4 (en) Detection of nucleic acids and proteins
ATE505562T1 (en) DOUBLE OLIGONUCLEOTIDE NUCLEIC ACID DETECTION METHOD
WO2008064304A3 (en) Compositions and methods for the identification of inhibitors of protein synthesis
MX2014003108A (en) Probe with multiple target region specificity and of tripartite character.
BR122020012978A8 (en) METHOD OF QUANTIFYING A SPECIFIC PRODUCT IN A CUTTING AND EXTENDING APLIFICATION REACTION (NEAR)

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: BIO-RAD LABORATORIES, INC.

Free format text: FORMER OWNER: BIO-RAD QL, INC

S73 Revocation on comptroller's initiative (section 73/patents act 1977)

Free format text: SPECIFICATION AMENDED